Visual function and dysfunction in early and late age-related maculopathy
- PMID: 16580242
- DOI: 10.1016/j.preteyeres.2005.11.002
Visual function and dysfunction in early and late age-related maculopathy
Abstract
Late age-related maculopathy (ARM) is responsible for the majority of blind registrations in the Western world among persons over 50 years of age. It has devastating effects on quality of life and independence and is becoming a major public health concern. Current treatment options are limited and most aim to slow progression rather than restore vision; therefore, early detection to identify those patients most suitable for these interventions is essential. In this work, we review the literature encompassing the investigation of visual function in ARM in order to highlight those visual function parameters which are affected very early in the disease process. We pay particular attention to measures of acuity, contrast sensitivity (CS), cone function, electrophysiology, visual adaptation, central visual field sensitivity and metamorphopsia. We also consider the impact of bilateral late ARM on visual function as well as the relationship between measures of vision function and self-reported visual functioning. Much interest has centred on the identification of functional changes which may predict progression to neovascular disease; therefore, we outline the longitudinal studies, which to date have reported dark-adaptation time, short-wavelength cone sensitivity, colour-match area effect, dark-adapted foveal sensitivity, foveal flicker sensitivity, slow recovery from glare and slower foveal electroretinogram implicit time as functional risk factors for the development of neovascular disease. Despite progress in this area, we emphasise the need for longitudinal studies designed in light of developments in disease classification and retinal imaging, which would ensure the correct classification of cases and controls, and provide increased understanding of the natural course and progression of the disease and further elucidate the structure-function relationships in this devastating disorder.
Similar articles
-
Psychophysical function in age-related maculopathy.Surv Ophthalmol. 2009 Mar-Apr;54(2):167-210. doi: 10.1016/j.survophthal.2008.12.003. Surv Ophthalmol. 2009. PMID: 19298899 Review.
-
Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.Ophthalmology. 2007 Sep;114(9):1728-35. doi: 10.1016/j.ophtha.2006.12.023. Ophthalmology. 2007. PMID: 17822978
-
Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1310-8. doi: 10.1167/iovs.05-1292. Invest Ophthalmol Vis Sci. 2006. PMID: 16565362 Clinical Trial.
-
Severity staging by early features of age-related maculopathy exhibits weak relationships with functional deficits on SWS grating acuity.Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4624-31. doi: 10.1167/iovs.05-1227. Invest Ophthalmol Vis Sci. 2006. PMID: 17003460
-
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.Prog Retin Eye Res. 2008 Jul;27(4):372-90. doi: 10.1016/j.preteyeres.2008.05.002. Epub 2008 Jul 14. Prog Retin Eye Res. 2008. PMID: 18621565 Review.
Cited by
-
Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5431-7. doi: 10.1167/iovs.09-4846. Epub 2010 Jun 16. Invest Ophthalmol Vis Sci. 2010. PMID: 20554607 Free PMC article. Clinical Trial.
-
Performance, usability and comparison of two versions of a new macular vision test: the handheld Radial Shape Discrimination test.PeerJ. 2016 Nov 1;4:e2650. doi: 10.7717/peerj.2650. eCollection 2016. PeerJ. 2016. PMID: 27833815 Free PMC article.
-
Prevalence and the risk factors for visual impairment in age-related macular degeneration.Eye (Lond). 2017 Jun;31(6):846-855. doi: 10.1038/eye.2017.72. Epub 2017 May 26. Eye (Lond). 2017. PMID: 28548646 Free PMC article.
-
VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION.Retina. 2016 May;36(5):1021-31. doi: 10.1097/IAE.0000000000001002. Retina. 2016. PMID: 26925551 Free PMC article.
-
[Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].Ophthalmologe. 2019 Dec;116(12):1186-1193. doi: 10.1007/s00347-019-0907-1. Ophthalmologe. 2019. PMID: 31087116 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical